by Ruth Kruger | Mar 16, 2022 | News
History of neurological or psychiatric conditions increases the likelihood of developing more People living with neurological or psychiatric conditions may have an increased likelihood of having a second such condition in the future, and their sex influences their...
by Ruth Kruger | Dec 7, 2021 | News
We are extremely proud to announce the release of the baseline dataset from our highly characterized Foundational Study of 520 people living with neurodegenerative disease and their care partners. Thank you to the clinicians, coordinators, patients and family members...
by Ruth Kruger | Nov 17, 2021 | News
The ‘TACKL-PRED (TACKLing the challenges of PREsymptomatic sporadic Dementia)’ study has received €1,086,421 in funding through the Joint Program in Neurodegenerative Disease (JPND) call entitled ‘Linking Pre-Diagnosis Disturbances of Physiological Systems to...
by Ashley Wilcox | Sep 23, 2021 | News
Congratulations to ONDRI’s co-lead Dr. Mario Masellis and the rest of the contributors to this important report. The World Azheimer Report 2021 focuses on the crucial and timely subject of diagnosis. Dr. Masellis’ contribution delves specifically into...
by Ashley Wilcox | Sep 14, 2021 | News
Queen’s University distinguished professor, researcher and ONDRI co-lead Doug Munoz, PhD has been elected to the Canadian Academy of Health Sciences (CAHS) Fellowship, one of Canada’s premier academic honours. Munoz is joined in this honour this year, by distinguished...
by Ruth Kruger | Aug 12, 2021 | News
Aducanumab, a possible treatment, or disease-modifying therapy, for Alzheimer’s disease (AD), developed by Biogen, is under evaluation for approval by Health Canada (HC). This follows its conditional approval by FDA in the United States, amidst significant...
